The American Pharmacists Association (APhA) announces a significant leadership transition within its autonomous division of the Board of Pharmacy Specialties (BPS). William Ellis, MS, RPh, ICE-CCP—after an impactful 14-year tenure as Executive Director of BPS—is retiring, effective January 10, 2025.

Washington, DC—APhA is deeply concerned about the ongoing reports of pharmacy closures, which primarily highlight the inconvenience of losing a local prescription source. However, this issue extends far beyond inconvenience; it jeopardizes access to trusted pharmacists, particularly in rural and underserved communities

WASHINGTON, DC – The American Pharmacists Association (APhA) and the University of Pittsburgh School of Pharmacy have released two new maps that visualize where community pharmacies offer immunization services in the United States. One interactive map will help patients find vaccinations close to home at easily accessible community pharmacies. A second map allows health care professionals and public health planners to explore geographic areas and vulnerable populations where pharmacists can be partners in expanding immunization efforts. These maps will be updated regularly to reflect pharmacy location changes to ensure accurate information.

WASHINGTON, DC — Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission’s (FTC) action today against alleged practices by large vertically integrated pharmacy benefit managers (PBMs) “for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower list price products, and shifted the cost of high insulin list prices to vulnerable patients.”